# Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings

> **NCT05343624** · NA · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Covid19
- Diabetes Mellitus

## Interventions

- **DEVICE:** continuous glucose monitoring

## Key facts

- **NCT ID:** NCT05343624
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05343624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05343624, "Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05343624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*